DekaBank Deutsche Girozentrale Has $8.76 Million Stock Position in Revvity Inc. (NYSE:RVTY)

DekaBank Deutsche Girozentrale decreased its holdings in shares of Revvity Inc. (NYSE:RVTY) by 0.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 84,383 shares of the company’s stock after selling 202 shares during the quarter. DekaBank Deutsche Girozentrale owned approximately 0.07% of Revvity worth $8,757,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of RVTY. T. Rowe Price Investment Management Inc. increased its stake in shares of Revvity by 16.7% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 20,761,308 shares of the company’s stock worth $2,317,170,000 after purchasing an additional 2,969,326 shares during the last quarter. EdgePoint Investment Group Inc. grew its stake in Revvity by 51.1% in the 4th quarter. EdgePoint Investment Group Inc. now owns 4,058,231 shares of the company’s stock valued at $452,939,000 after buying an additional 1,372,456 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in Revvity by 17.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 7,631,597 shares of the company’s stock valued at $851,764,000 after buying an additional 1,151,821 shares during the last quarter. Norges Bank acquired a new position in Revvity in the 4th quarter valued at $127,801,000. Finally, GAMMA Investing LLC grew its stake in Revvity by 15,023.0% in the 1st quarter. GAMMA Investing LLC now owns 287,035 shares of the company’s stock valued at $30,368,000 after buying an additional 285,137 shares during the last quarter. Institutional investors and hedge funds own 86.65% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. JPMorgan Chase & Co. lowered their target price on shares of Revvity from $120.00 to $100.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 29th. Wall Street Zen upgraded shares of Revvity from a “hold” rating to a “buy” rating in a research note on Saturday, June 28th. Raymond James Financial reiterated an “outperform” rating and issued a $120.00 target price (down from $145.00) on shares of Revvity in a research note on Tuesday, April 29th. Bank of America lowered their target price on shares of Revvity from $116.00 to $110.00 and set a “buy” rating on the stock in a research note on Thursday, June 26th. Finally, UBS Group upgraded shares of Revvity from a “neutral” rating to a “buy” rating and lowered their target price for the company from $145.00 to $115.00 in a research note on Thursday, May 1st. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $123.07.

Revvity Price Performance

NYSE:RVTY opened at $101.49 on Friday. The company has a 50-day moving average of $94.71 and a 200-day moving average of $104.53. The company has a market capitalization of $11.96 billion, a price-to-earnings ratio of 43.19, a PEG ratio of 2.58 and a beta of 0.98. Revvity Inc. has a 52 week low of $87.70 and a 52 week high of $129.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.99 and a current ratio of 3.58.

Revvity (NYSE:RVTY) last released its quarterly earnings data on Monday, April 28th. The company reported $1.01 EPS for the quarter, topping analysts’ consensus estimates of $0.96 by $0.05. The company had revenue of $664.76 million during the quarter, compared to the consensus estimate of $662.30 million. Revvity had a net margin of 10.35% and a return on equity of 7.73%. The firm’s revenue for the quarter was up 2.3% compared to the same quarter last year. During the same period last year, the firm earned $0.98 EPS. As a group, equities research analysts anticipate that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.28%. The ex-dividend date of this dividend is Friday, July 18th. Revvity’s payout ratio is 11.91%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.